Physicochemical characterization of protamine-phosphorothioate nanoparticles.
Protamine-oligonucleotide nanoparticles represent effective colloidal drug carriers for antisense phosphorothioate oligonucleotides (PTO). This study describes improvements in particle preparation and the physicochemical properties of the complexes prepared. The influence of component concentrations, length of the PTO chain and the PTO/protamine weight ratio on particle formation and size, shape and surface charge of the particles were studied in detail. Nanoparticles with diameters of 90-200nm were obtained, using protamine free base (PFB) and phosphorothioate in water. The chemical composition of the nanoparticles was analysed. More than 90% of the PTO could be assembled in the particle matrix using a > or = 1:2 ratio (w/w) of PTO and PFB. About 53-68% of the PFB was incorporated in the particle matrix. The complexes had a zetapotential of -19 up to +32 mV, depending on the PTO/PFB ratio. The kinetics of the assembly of this binary system were observed by dynamic light scattering (DLS) measurements and by sedimentation velocity analysis in the analytical ultracentrifuge (AUC). In addition, scanning electron microscopy (SEM) and atomic force microscopy (AFM) were applied to verify the results of DLS and the ultracentrifuge measurements. According to sedimentation velocity analysis, the particles were only moderately stable in water and unstable in salt solutions. However, the colloidal solution in water could be stabilized by polyethylenglycol 20000 (PEG), which also led to an increase of stability in cell medium.
Lochmann
D
D
Institute for Pharmaceutical Technology, Johann Wolfgang Goethe-University, Marie-Curie-Strasse 9, 60439 Frankfurt am Main, Germany.
Vogel
V
V
Weyermann
J
J
Dinauer
N
N
von Briesen
H
H
Kreuter
J
J
Schubert
D
D
Zimmer
A
A
D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004337:Drug Carriers / Q000737:chemistry; D004339:Drug Compounding / Q000379:methods; D004355:Drug Stability; D008027:Light; D018625:Microscopy, Atomic Force / Q000379:methods; D008855:Microscopy, Electron, Scanning / Q000379:methods; D008970:Molecular Weight; D049329:Nanostructures / Q000737:chemistry*; D016376:Oligonucleotides, Antisense / Q000737:chemistry*; D010316:Particle Size; D010710:Phosphates / Q000737:chemistry*; D011479:Protamines / Q000737:chemistry*; D012542:Scattering, Radiation; D013499:Surface Properties; D014461:Ultracentrifugation / Q000379:methods
D004337:Drug Carriers; D016376:Oligonucleotides, Antisense; D010710:Phosphates; D011479:Protamines; C083120:phosphorodithioic acid